On Friday, Revolution Medicines Inc (NASDAQ: RVMD) opened lower -1.76% from the last session, before settling in for the closing price of $47.25. Price fluctuations for RVMD have ranged from $18.00 to $51.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 11.11% over the last five years. Company’s average yearly earnings per share was noted 12.47% at the time writing. With a float of $139.21 million, this company’s outstanding shares have now reached $164.67 million.
The firm has a total of 378 workers. Let’s measure their productivity. In terms of profitability, gross margin is -1323.58%, operating margin of -80961.32%, and the pretax margin is -70448.92%.
Revolution Medicines Inc (RVMD) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Revolution Medicines Inc is 16.66%, while institutional ownership is 87.25%. The most recent insider transaction that took place on Oct 14 ’24, was worth 824,804. In this transaction an insider of this company sold 16,666 shares at a rate of $49.49, taking the stock ownership to the 264,408 shares. Before that another transaction happened on Oct 11 ’24, when Company’s Chief Operating Officer sold 50,000 for $50.34, making the entire transaction worth $2,517,055. This insider now owns 132,320 shares in total.
Revolution Medicines Inc (RVMD) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.99 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.01) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.47% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Check out the current performance indicators for Revolution Medicines Inc (RVMD). In the past quarter, the stock posted a quick ratio of 15.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10478.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.65, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.89 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Analysing the last 5-days average volume posted by the [Revolution Medicines Inc, RVMD], we can find that recorded value of 1.62 million was better than the volume posted last year of 1.31 million. As of the previous 9 days, the stock’s Stochastic %D was 28.01%. Additionally, its Average True Range was 1.97.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 68.46%, which indicates a significant increase from 8.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.38% in the past 14 days, which was higher than the 39.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.27, while its 200-day Moving Average is $38.34. Now, the first resistance to watch is $48.15. This is followed by the second major resistance level at $49.89. The third major resistance level sits at $50.79. If the price goes on to break the first support level at $45.51, it is likely to go to the next support level at $44.61. Should the price break the second support level, the third support level stands at $42.87.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
There are currently 164,986K shares outstanding in the company with a market cap of 7.75 billion. Presently, the company’s annual sales total 11,580 K according to its annual income of -436,370 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -116,000 K.
